Tau Loss Modifies Network Excitability in Glioma-Associated Epilepsy
Abstract number :
2.004
Submission category :
1. Translational Research: 1A. Mechanisms / 1A1. Epileptogenesis of acquired epilepsies
Year :
2017
Submission ID :
348238
Source :
www.aesnet.org
Presentation date :
12/3/2017 3:07:12 PM
Published date :
Nov 20, 2017, 11:02 AM
Authors :
Asante Hatcher, Baylor College of Medicine; Kwanha Yu, Baylor College of Medicine; Isamu Aiba, Baylor College of Medicine; Bemjamin Deneen, Baylor College of Medicine; and Jeffrey Noebels, Baylor College of Medicine
Rationale: Hyper-excitability of neuronal networks underlies the pathophysiology of epilepsy, and is known to be a component of other neurological disorders including cancers of the brain. Previous work has shown that genetic removal of neuronal microtubule organizer and stabilizer tau can significantly reduce epileptiform activity and lethality across a number of models of hyper-excitability, including Alzheimer’s Disease models, the Kcna1 early lethal mouse model of epilepsy, and the Scn1a mouse model of Dravet syndrome. We recently confirmed a progressive seizure phenotype in a novel transgenic mouse model of brain tumor associated epilepsy. The effect of tau loss on hyper-excitability and lethality in this glioblastoma model is unknown. Methods: To answer this question, we generated glial derived brain tumors on a tau knockout background using a CRISPR in utero electroporation strategy. Using chronic video electroencephalography (EEG), we recorded cortical inter-ictal spike and seizure activity in these tumor mice at various timepoints in disease progression, monitored survival, and assessed tumor burden via immunohistochemically methods. Results: tau KO tumor mice exhibited reduced inter-ictal spike activity and slightly longer survival margins compared to tau WT tumor-bearing littermates Conclusions: These data suggest that tau loss may provide a modest protective effect in this model of cortical hyper-excitability Funding: This work was supported by grants from NIH NS29709(JLN), CPRIT (BD), and HHMI Gilliam Fellowship (AH).
Translational Research